JENNIFER L MULLER MD NPI 1790763985

NPI Details

Jennifer L Muller, MD is a medical oncology internal medicine in Naples, FL with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Jennifer L Muller, MD NPI is 1790763985. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Graduation Year:1997

The provider's business location address is:

6360 PINE RIDGE RD STE 201
NAPLES, FL
ZIP 34119-907
Phone: (239) 353-6636

The NPI 1790763985 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Folic acid level, serum (HCPCS:82746)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Uric acid level, blood (HCPCS:84550)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Magnesium level (HCPCS:83735)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Drawing of blood for a medical problem (HCPCS:99195)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood count, manual test (HCPCS:85044)
• Testosterone (hormone) level, total (HCPCS:84403)
• Red blood count, automated test (HCPCS:85045)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Vitamin d-3 level (HCPCS:82306)
• Erythropoietin (protein) level (HCPCS:82668)

The enumeration date for this NPI number is 1/6/2006 and was last updated on 8/11/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.